PYPekka Ylipalosaari

Pekka Ylipalosaari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pekka Ylipalosaari has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Guillain–Barré syndrome and ulceroglandular tularemia

    by P. Ylipalosaari, T. I. Ala-Kokko, H. Tuominen, H. Syrjälä

    Francisella tularensis is a small Gram-negative aerobic intracellular bacterium that should be considered as a possible pathogen in patients with fever, pharyngitis, and lymphadenopathia. Central nervous system manifestations have been rarely reported. We describe a patient who developed serious Guillain–Barré polyneuropathy as a rare complication of ulceroglandular tularemia.


  • Open Access

    Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment

    by Pekka Ylipalosaari, Tero I Ala-Kokko, Juha Karhu, Markku Koskela, Jouko Laurila, Pasi Ohtonen, Hannu Syrjälä

    The aim of this study was to compare the epidemiology, risk factors, severity and outcome of two types of intensive care unit (ICU) treated candidemias; namely, ICU-acquired candidemia (acquired after 48-hour ICU stay) ( ICUAC group), and those needing ICU treatment for candidemia acquired before ICU admission or during the first 48-hour ICU stay (non-ICUAC group).


    • 1 January 2011
      • Vol. 127  (14) , 1449-56

    [Infection control in the intensive care unit].

    by Pekka Ylipalosaari, Tero Ala-Kokko, Hannu Syrjälä

    The basis of infection control is systematic monitoring of infections in the patient care units, whereby a clear-cut basis for focusing of the control is obtained. An entity of several distinct evidence-based methods, i.e. treatment bundle, is increasingly utilized. Though difficult in practice, the goal is zero tolerance, whereby all infections during the treatment should be prevented. Central principles of infection control include use of antimicrobial hand rinse in all patient care, appropriate use of protective devices and contact isolation as required by the detected microorganisms.

  • Open Access

    Intensive care unit acquired infection has no impact on long-term survival or quality of life: a prospective cohort study

    by Pekka Ylipalosaari, Tero I Ala-Kokko, Jouko Laurila, Pasi Ohtonen, Hannu Syrjälä

    Introduction: The aim of this study was to evaluate the impact of intensive care unit (ICU)-acquired infection on long-term survival and quality of life. Methods: Long-term survival was prospectively evaluated among hospital survivors who had stayed in a mixed, university-level ICU for longer than 48 hours during a 14-month study period during 2002 to 2003. Health-related quality of life was assessed using the five-dimensional EuroQol (EQ-5D) questionnaire in January 2005. Results: Of the 272 hospital survivors, 83 (30.5%) died after discharge during the follow-up period. The median follow-up time after hospital discharge was 22 months. Among patients without infection on admission, long-term mortality did not differ between patients who developed and those who did not develop an ICU-acquired infection (21.7% versus 26.9%; P = 0.41). Also, among patients with infection on admission, there was no difference in long-term mortality between patients who developed a superimposed (35.1%) and those who did not develop a superimposed (27.6%) ICU-acquired infection (P = 0.40). The EQ-5D response rate was 75 %. The patients who developed an ICU-acquired infection had significantly more problems with self-care (50%) than did those without an ICU-acquired infection (32%; P = 0.004), whereas multivariate analysis did not show ICU-acquired infection to be a significant risk factor for diminished self-care (odds ratio = 1.71, 95% confidence interval = 0.65–4.54; P = 0.28). General health status did not differ between those with and those without an ICU-acquired infection, as measured using the EuroQol visual-analogue scale (mean ± standard deviation EuroQol visual-analogue scale value: 60.2 ± 21 in patients without ICU-acquired infection versus 60.6 ± 22 in those with ICU-acquired infection). The current general level of health compared with status before ICU admission did not differ between the groups either. Only 36% of those employed resumed their previous jobs. Conclusion: ICU-acquired infection had no impact on long-term survival. The patients with ICU-acquired infection more frequently experienced problems with self-care than did those without ICU infection, but ICU-acquired infection was not a significant risk factor for diminished self-care in multivariate analysis.


  • Epidemiology of intensive care unit (ICU)‐acquired infections in a 14‐month prospective cohort study in a single mixed Scandinavian university hospital ICU

    by P Ylipalosaari, T. I. Ala‐Kokko, J Laurila, P Ohtonen, H Syrjälä

    Background:  Our aim was to evaluate the epidemiology of intensive care unit (ICU)‐acquired infections in a prospective cohort study.Methods:  Patients with longer than a 48‐h stay in an adult mixed medical–surgical ICU in a tertiary level teaching hospital were included. The incidence (per cent) and incidence density (per 1000 patient days) of ICU‐acquired infections and the device‐associated infection rates per 1000 device days were analysed prospectively in a 14‐month study.Results:  Eighty (23.9%) of 335 patients, whose ICU stay was longer than 48 h, acquired a total of 107 infections (1.3 per patient) during their ICU stay, with an infection rate of 48 per 1000 patient days. The most common infections were ventilator‐associated pneumonia (VAP) [33.8% (18.8 per 1000 respiratory days)], other lower respiratory tract infections (LRTIs) (20%) and sinusitis (13.8%). The rate of central catheter‐related (CRI) or primary bloodstream infections was 6.3% (2.2 per 1000 central venous catheter days), and the rate of urinary tract infections was 1.3% (0.5 per 1000 urinary catheter days). The first ICU infection was observed in 58.8% (47/80) of cases within 6 days after admission. The median time from admission to the diagnosis of an ICU‐acquired infection was 4 days (25th–75th percentiles, 4.0–6.0) for VAP, 6.0 days (4.5–7.0) for LRTIs and 9.5 days (6.5–13.0) for CRIs.Conclusions:  The rates of urinary tract infections and bloodstream infections were lower than reported previously, differentiating our results from the classic pattern of ICU‐acquired infections, with the exception of the predominance of VAP.


  • Community- and hospital-acquired infections necessitating ICU admission: Spectrum, co-morbidities and outcome

    by Pekka Ylipalosaari, Tero I. Ala-Kokko, Jouko Laurila, Pasi Ohtonen, Hannu Syrjälä


  • Open Access

    Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study

    by Pekka Ylipalosaari, Tero I Ala-Kokko, Jouko Laurila, Pasi Ohtonen, Hannu Syrjälä

    Introduction: The aim of this study was to elucidate the impact of intensive care unit (ICU)-acquired infection on hospital mortality. Methods: Patients with a longer than 48 hour stay in a mixed 10 bed ICU in a tertiary-level teaching hospital were prospectively enrolled between May 2002 and June 2003. Risk factors for hospital mortality were analyzed with a logistic regression model. Results: Of 335 patients, 80 developed ICU-acquired infection. Among the patients with ICU-acquired infections, hospital mortality was always higher, regardless of whether or not the patients had had infection on admission (infection on admission group (IAG), 35.6% versus 17%, p = 0.008; and no-IAG, 25.7% versus 6.1%, p = 0.023). In IAG (n = 251), hospital stay was also longer in the presence of ICU-acquired infection (median 31 versus 16 days, p < 0.001), whereas in no-IAG (n = 84), hospital stay was almost identical with and without the presence of ICU-acquired infection (18 versus 17 days). In univariate analysis, the significant risk factors for hospital mortality were: Acute Physiology and Chronic Health Evaluation (APACHE) II score >20, sequential organ failure assessment (SOFA) score >8, ICU-acquired infection, age ≥ 65, community-acquired pneumonia, malignancy or immunosuppressive medication, and ICU length of stay >5 days. In multivariate logistic regression analysis, ICU-acquired infection remained an independent risk factor for hospital mortality after adjustment for APACHE II score and age (odds ratio (OR) 4.0 (95% confidence interval (CI): 2.0–7.9)) and SOFA score and age (OR 2.7 (95% CI: 2.9–7.6)). Conclusion: ICU-acquired infection was an independent risk factor for hospital mortality even after adjustment for the APACHE II or SOFA scores and age.